16-28479196-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001042432.2(CLN3):​c.1057-1319A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.323 in 152,140 control chromosomes in the GnomAD database, including 9,292 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 9292 hom., cov: 32)

Consequence

CLN3
NM_001042432.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0800

Publications

84 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Myriad Women's Health

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001042432.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.405 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042432.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
NM_001042432.2
MANE Select
c.1057-1319A>G
intron
N/ANP_001035897.1Q13286-1
CLN3
NM_000086.2
c.1057-1319A>G
intron
N/ANP_000077.1Q13286-1
CLN3
NM_001286104.2
c.985-1319A>G
intron
N/ANP_001273033.1Q13286-7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
ENST00000636147.2
TSL:1 MANE Select
c.1057-1319A>G
intron
N/AENSP00000490105.1Q13286-1
CLN3
ENST00000359984.12
TSL:1
c.1057-1319A>G
intron
N/AENSP00000353073.9Q13286-1
CLN3
ENST00000565316.6
TSL:1
c.1006-1319A>G
intron
N/AENSP00000456117.1Q13286-3

Frequencies

GnomAD3 genomes
AF:
0.323
AC:
49076
AN:
152022
Hom.:
9281
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.221
Gnomad AMR
AF:
0.400
Gnomad ASJ
AF:
0.283
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.217
Gnomad FIN
AF:
0.482
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.409
Gnomad OTH
AF:
0.302
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.323
AC:
49127
AN:
152140
Hom.:
9292
Cov.:
32
AF XY:
0.323
AC XY:
24014
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.158
AC:
6576
AN:
41536
American (AMR)
AF:
0.401
AC:
6130
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
982
AN:
3470
East Asian (EAS)
AF:
0.117
AC:
605
AN:
5178
South Asian (SAS)
AF:
0.217
AC:
1048
AN:
4824
European-Finnish (FIN)
AF:
0.482
AC:
5090
AN:
10558
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.409
AC:
27789
AN:
67980
Other (OTH)
AF:
0.305
AC:
642
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1639
3278
4917
6556
8195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.371
Hom.:
41644
Bravo
AF:
0.310
Asia WGS
AF:
0.244
AC:
847
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
2.6
DANN
Benign
0.54
PhyloP100
-0.080
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs151181;
hg19: chr16-28490517;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.